Cite
Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
MLA
Zhang, Xiaojie, et al. “Design, Synthesis, and Biological Evaluation of 1,9-Diheteroarylnona-1,3,6,8-Tetraen-5-Ones as a New Class of Anti-Prostate Cancer Agents.” Bioorganic & Medicinal Chemistry, vol. 24, no. 19, Oct. 2016, pp. 4692–700. EBSCOhost, https://doi.org/10.1016/j.bmc.2016.08.006.
APA
Zhang, X., Wang, R., Perez, G. R., Chen, G., Zhang, Q., Zheng, S., Wang, G., & Chen, Q.-H. (2016). Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents. Bioorganic & Medicinal Chemistry, 24(19), 4692–4700. https://doi.org/10.1016/j.bmc.2016.08.006
Chicago
Zhang, Xiaojie, Rubing Wang, German Ruiz Perez, Guanglin Chen, Qiang Zhang, Shilong Zheng, Guangdi Wang, and Qiao-Hong Chen. 2016. “Design, Synthesis, and Biological Evaluation of 1,9-Diheteroarylnona-1,3,6,8-Tetraen-5-Ones as a New Class of Anti-Prostate Cancer Agents.” Bioorganic & Medicinal Chemistry 24 (19): 4692–4700. doi:10.1016/j.bmc.2016.08.006.